Search arXiv⌕ Search

arXiv · 2610.18794

Brain Age Gap Progression in Individuals at Risk for Neurodegeneration

Abstract

Neuroimaging is a widely used modality for characterizing neurodegeneration in various health conditions. Brain age gap has emerged as a promising biomarker for monitoring brain health from neuroimaging data using machine learning algorithms. Recent studies have leveraged coVariance neural networks (VNN)-driven pipelines based on the advancements in graph signal processing for relatively transparent construction of brain age gap from neuroimaging data. In this paper, we focus on a longitudinal study of VNN-based brain age gap in conjunction with Alzheimer's Progression Score (APS) in individuals that are at a higher risk of neurodegeneration due to family history of Alzheimer's disease. APS is a multimodal marker of disease progression. The longitudinal analysis of APS and VNN-derived brain age gap metrics revealed that a higher risk of disease progression at baseline predicted a larger rate of increase in brain age gap in follow-up visits. Thus, our findings revealed potential stratification in the brain age gap modulated by clinical/biological risks of AD in the at-risk population.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jason Scheffel, Saurabh Sihag. 2026-10-13. Brain Age Gap Progression in Individuals at Risk for Neurodegeneration. https://arxiv.org/abs/2610.18794

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Imaging-anchored Multiomics in Cardiovascular Disease: Integrating Cardiac Imaging, Bulk, Single-cell, and Spatial Transcriptomics

Cardiovascular disease arises from interactions between inherited risk, molecular programmes, and tissue-scale remodelling that are observed clinically through imaging. Health systems now routinely generate large volumes of cardiac MRI, CT and echocardiography together with bulk, single-cell and spatial transcriptomics, yet these data are still analysed in separate pipelines. This review examines joint representations that link cardiac imaging phenotypes to transcriptomic and spatially resolved molecular states. An imaging-anchored perspective is adopted in which echocardiography, cardiac MRI and CT define a spatial phenotype of the heart, and bulk, single-cell and spatial transcriptomics provide cell-type- and location-specific molecular context. The biological and technical characteristics of these modalities are first summarised, and representation-learning strategies for each are outlined. Multimodal fusion approaches are reviewed, with emphasis on handling missing data, limited sample size, and batch effects. Finally, integrative pipelines for radiogenomics, spatial molecular alignment, and image-based prediction of gene expression are discussed, together with common failure modes, practical considerations, and open challenges. Spatial multiomics of human myocardium and atherosclerotic plaque, single-cell and spatial foundation models, and multimodal medical foundation models are collectively bringing imaging-anchored multiomics closer to large-scale cardiovascular translation.

q-bio.QM↗

Stochastic partial differential equation model for environmental DNA dynamics in river environments

Environmental DNA (eDNA) has emerged as a novel tool for quantifying the seasonal abundance of aquatic species in water bodies; however, its mathematical modeling is still at a germinating stage because of its mechanistic uncertainties. We propose a first-step mathematical and computational framework for the eDNA dynamics of migratory fish based on a novel stochastic partial differential equation model with a delayed source input. The model governs spatiotemporal eDNA concentration in rivers where the source comes from a stochastic differential equation for the migration dynamics of the fish. The affine nature of the model facilitates its theoretical analysis, including the guarantee of well-posedness and the closed-form derivation of the Laplace functional despite the proportionality coefficient of the multiplicative noise term being non-Lipschitz. We also propose a discretization scheme for the model that theoretically generates nonnegative numerical solutions. We finally apply the proposed model to eDNA concentration data sampled from midstream reaches of a river system and perform sensitivity analysis.

q-bio.QM↗

Maximum likelihood, neural networks and posterior mean for inferring fractional Brownian motion parameters

Fractional Brownian motion (fBM) is a model of anomalous diffusion parameterised by a Hurst exponent $H \in (0,1)$ and a generalised diffusion coefficient $D_H > 0$. We jointly estimate $H$ and $D_H$ using maximum likelihood (MLE) from density measurements with Poisson counting noise and single-particle trajectory with Gaussian localisation error. We show that one density measurement in time cannot infer both $H$ and $D_H$ and that several time points are needed, which matters most for inference precision. For trajectories, we show that a neural network trained with a squared error loss approximates the posterior mean of $H$, which can be computed exactly at negligible cost. Paired with the profile-likelihood estimate of $D_H$, the posterior mean has the lowest root mean squared error in both $H$ and $D_H$, except near $H=0$ and $H=1$ where MLE estimates $H$ better. In vesicle trajectories from two cell types, $H$ and $D_H$ form a continuum rather than distinct modes of motion. The posterior probability that each window within a track is subdiffusive or superdiffusive shows that $26\%$ of MRC5 fibroblast and $21\%$ of HeLa vesicle trajectories contain both subdiffusive and superdiffusive windows, against $2\%$ and $7\%$ expected from estimation uncertainty alone. Intracellular cargoes therefore switch between subdiffusion and superdiffusion over time rather than forming populations with fixed $H$.

q-bio.QM↗